Capricor Therapeutics CAPR Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $0-100% | $22.27M-11.5% | $25.18M— | —— | ||
| $84.45M+69.0% | $49.97M+37.1% | $36.45M+67.1% | $21.82M+60.8% | ||
| $23.69M+59.3% | $14.87M+16.1% | $12.81M+22.8% | $10.43M+37.0% | ||
| $108.14M+66.8% | $64.83M+31.6% | $49.26M+52.7% | $32.25M+52.2% | ||
| -$108.14M-154% | -$42.56M-76.8% | -$24.08M+18.9% | -$29.7M-41.8% | ||
| —— | $2.1M+17.2% | $1.79M+164% | $677.85K-26.0% | ||
| —— | -$40.47M— | —— | —— | ||
| —— | $1.6K— | —— | —— | ||
| -$105.04M-160% | -$40.47M-81.6% | -$22.29M+23.2% | -$29.02M-44.9% | ||
| -$2.26-96.5% | -$1.15-35.3% | -$0.85+28.0% | -$1.18-35.6% | ||
| -$106.25M-158% | -$41.14M-78.8% | -$23.01M+21.1% | -$29.16M-40.9% | ||
| -$108.14M-154% | -$42.56M-76.8% | -$24.08M+18.9% | -$29.7M-41.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Capricor Therapeutics's income statement data come from?
- Every line is extracted from Capricor Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.